Trial intelligence / Profile preview

DECIDE: Metformin vs Insulin for Gestational Diabetes

NCT06445946Phase 4Recruiting

Sponsor
The Ohio State University
Start
Aug 2024
Primary completion
Dec 2029
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of liquid metformin (Aspargo Labs) in gestational diabetes mellitus (GDM), sponsored by The Ohio State University. Started Aug 2024; status: recruiting.

02

Drugs

liquid metformin (Aspargo Labs)
03

Conditions

gestational diabetes mellitus (GDM)

Beyond the preview

Go deeper on NCT06445946.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06445946.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call